The only curative treatment for liver metastases is surgical resection. However, only 5-10% of patients with hepatic metastases from colorectal cancer are amenable to this type of therapy, and the operative mortality and morbidity rates are relatively high (4-25% and 16-46%, respectively) (Steele & Ravikumar, 1989; Sugerbaker & Kemeny, 1989; Wagman et al., 1990) . Photodynamic therapy (PDT) is a relatively new local treatment modality, which has been used successfully in the treatment of various malignant tumours, including cancer of the bladder, skin, upper respiratory tract and gastrointestinal tract (Dougherty, 1987; Manyak et al., 1988; Gomer, 1989; Wilson et al., 1991) . This type of therapy is based on the accumulation of a photosensitiser in malignant tissues and the subsequent illumination with light of an appropriate wavelength, which creates a reactive species that upon decay to its ground state transforms available oxygen into singlet oxygen. It is this very reactive singlet oxygen which is thought to be the most important cytotoxic agent in PDT, causing direct damage to many cellular sites like plasma membrane, microsomes, mitochondria and nucleus as well as to the microvasculature (Weishaupt et al., 1976; Star et al., 1986; Henderson & Bellnier, 1989; Fingar et al., 1990) . The most common photosensitisers are haematoporphyrin derivative (Hpd), a mixture of various porphyrins and Photofrin®, a substance derived from Hpd and enriched in the photodynamically active fraction (Lipson et al., 1961; Dougherty et al., 1984; Kessel et al., 1987; Bonnet & Berenbaum, 1989; Gomer et al., 1989) .
Until now the application in liver tumours has been restricted as liver tissue accumulates Photofrin more efficiently than the malignant tissue (Gomer & Dougherty, 1979; Bugelski et al., 1981; Cozzani et al., 1984; Bellnier et al., 1989) . Therefore, superficial tumour illumination causes substantial liver necrosis (Pimstone et al., 1982) . Moreover, the limited light penetration during superficial illumination makes it impossible to treat deep-seated or larger solid tumours (Doiron et al., 1983) . These limitations could be overcome by implanting the light delivery fibres with diffusing cylinder tips directly into the tumour (interstitial therapy), thus applying the light selectively and with greater accessibility Holt et al., 1985; Arnfield et al., 1986; Gatenby et al., 1987; Marijnissen et al., 1992) .
In the present study we therefore investigated the effects of photodynamic therapy on tumour and surrounding normal hepatic tissue using interstitial illuminations in a rat liver metastasis model.
Materials and methods

Animals
One hundred and eight male Wag/Rij rats (Harlan CPB, Austerlitz, The Netherlands), weighing 180-200g were used for the experiments. They had free access to rat chow and tap water. All animals received humane care, in accordance with the guidelines for experimental animals of the Erasmus University Rotterdam.
Tumour model
Colon adenocarcinoma CC531, a moderately differentiated and syngeneic tumour transplantable to Wag/Rij rats, was maintained subcutaneously (Marquet et al., 1984) . Doubling time was 2 weeks. On the day of inoculation the tumour was excised from the donor rat, cut into pieces of approximately 2 mm3 and kept in Hank's balanced salt solution (HBBS).
Under ether anaesthesia a small midline laparotomy was performed, followed by an incision in the left lateral lobe of the liver. A piece of tumour was implanted and covered with long-term effects, especially in relation to tumour remission.
In experiment I the animals were randomly assigned to four groups: The experimental group (Photofrin and light, n = 6 per light dose), a control group (laser light only, n = 6 per light dose), a control group (Photofrin only, n = 6) and a control group (diffuser insertion only, n = 6). Two days before laser illumination Photofrin was administered. On the first and second day after laser treatment, blood was collected for serum aspartate animotransferase (ASAT) and alanine aminotransferase (ALAT) determination. On the second day after laser, the animals were killed and the liver was removed for histological determination of short-term effects.
In experiment II the animals were randomly assigned to two groups. The experimental group (n = 6 per light dose) underwent the same treatment as in experiment I. The animals in the control group (n = 6) received Photofrin without any laser illumination. To determine liver function, an antipyrine clearance test was performed on the first day after laser treatment. All animals were killed on day 36 after laser treatment for histological determination of long-term effects. (Star et al., 1990 Tumour temperature was determined with a needle thermocouple (Type C-N5, Exacon) connected to a read-out instrument (Model MC-9200, Exacon) that was positioned at the edge of the tumour (Figure 1 ). The tumour periphery was chosen for these measurements, as this would be the most critical region for complete tumour cell destruction due to the central diffuser position.
Determination ofphotodynamic effects Histopathology After fixation in a 3.6% buffered formalin solution for 5 days the livers were sliced through the plane of the largest tumour diameter, embedded in paraffine and sectioned at 5 gm. Sections were mounted on glass slides and stained with haematoxylin, azophloxin and saffron, for lightmicroscopical examination.
Tissue damage On slides taken from animals killed on the second day after PDT treatment the areas of hepatic necrosis and vital or necrotic tumour were calculated by computerassisted integration of the circumference (IBAS 2000, Kontron Bildanalyse GmbH, Munich, Germany). The maximal width of the rim of hepatic necrosis was determined by IBAS assisted measurements.
Tumour remission Tumour remission was assessed on the basis of specimens taken from animals sacrificed 36 days after PDT treatment. Complete tumour remission was considered when no tumour outgrowth (i.e. no vital tumour tissue) could be observed by light microscopy. Additionally the tumour area was measured by IBAS to give an indication of tumour growth retardation.
Serum ASA T/ALA T To measure the amount of liver damage the levels of serum ASAT and ALAT were determined in 0.5 ml blood on the first and second day after laser treatment using standard laboratory equipment and techniques at 30°C.
Antipyrine clearance test Liver function was determined by antipyrine clearance on the first day after treatment. Antipyrine in a dose of 100 mg kg-' body weight was administered by penile vein injection and blood samples of 0.5 ml were collected by orbital puncture 1, 2 and 4 h after administration. The plasma elimination half-life (T1/2) was then determined from antipyrine levels measured by high-pressure liquid chromatography according to Shargel et al. (1979) .
All determinations were performed without knowledge of treatment parameters. .:
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Results
In one animal the tumour implant did not grow; another animal died during anaesthesia. All remaining animals survived and none of the animals showed signs of discomfort after PDT treatment.
On the day of laser illumination the mean visible tumour diameter of all animals (n = 106) was 5.7 ± 0.1 mm varying from 4.0 to 8.0 mm.
Temperature andfluence With 400 J cm-' from the diffuser a fluence of 170 ± 30 J cm 2 was measured at the boundary of 5.5 ± 0.5 mm diameter tumour (n = 5). Slight changes in light penetration through the tumour could be observed during PDT treatment.
Baseline rectal temperature was 31.9 ± 0.4C (n = 18), remaining constant during PDT treatment. The tumour core temperature was 29.7 ± 0.6°C, varying from 27.5 to 34.3°C. Generally the temperature at the tumour boundary increased during illumination with a mean value of 3.3 ± 0.3°C, ranging from 0.2 to 6°C. The absolute tissue temperature was always less than 40°C. Tissue changes as previously observed after thermal laser therapy, such as charring, cavitation or elongation of cellular nuclei 1992a) could not be identified in illuminated areas.
Histopathology
The general pattern of PDT induced tissue damage and subsequent healing was unaffected by the variations in light energy applied (Figure 2 (Figures 2b, 4) . Remarkably, the hepatic tissue had remained intact around the portal areas ( Figure 6 ). A second zone of inflammatory infiltrate surrounded the hepatic necrosis.
Thirty-six days after PDT treatment two different situations could be observed:
(1) Complete tumour remission ( Figure 2c) ; the necrotic area was replaced by regenerated liver tissue and connective scar tissue in which a granulomatous reaction with multinucleated giant cells was present ( Figure 3c ). (2) Tumour outgrowth, probably from the remaining islands of vital tumour tissue.
Short-term photodynamic effects
Tissue damage The mean ( ± s.e.) tumour diameter, derived from areal measurements on short-term histological samples (n = 71) was 5.8 ± 0.1 mm. Maximal width of the surrounding rim of liver necrosis varied from 2.6 ± 0.2 mm, after 100 J cm-' illumination to 3.7 ± 0.4 after 400 J cm-'.
The results of the measurements on the areas of hepatic necrosis and vital or necrotic tumour are shown in Table I .
The total (i.e. vital + necrotic) tumour area ranged from 10.2 mm2 to 36.9 mm2 with a mean ( ± s.e.) value of 26.7 + 0.7 mm2 (n = 71). The mean ( ± s.e.) tumour necrosis varied from 3.4 ± 0.6 mm2 after Photofrin administration only, to 23.6 ± 0.8 mm2 in the experimental group treated with 1600 J cm-'. Mean ( ± s.e.) vital tumour area was 26.9 ± 1.7 mm2 in controls after Photofrin only, and 0.2 ± 0.1 mm2 after PDT with 1600 J cm-'. Hepatic necrosis occurred in all experimental groups, with a mean (± s.e.) maximal value of 30.5 ± 1.4 mm2 after 1600 J cm-'.
As the amount of tumour necrosis is related to tumour size, each measurement was expressed as percentage of the individual total tumour area. For comparison, the same was done for liver necrosis (Figure 7 ). Tumour necrosis was found to increase with light energy delivered, with mean values of 60.6 ± 6.6% at 100 J cmu' compared with 99.0 ± 0.6% at 1600 J cm-' (P<0.001). Liver necrosis was also related to light energy, ranging from 87.8 ± 9.8% at 100 J cm-' to 128.8 ± 8.3% at 1600 J cm-' (P = 0.001) (Figure 7a ).
Control animals treated with Photofrin only, showed the usual pre-existent central tumour necrosis, measuring 11.1 ± 1.7%. Diffuser insertion did not cause additional damage (P = 0.09). However, after laser illumination only, a significant relationship was found between tumour (P= 0.003) or liver (P = 0.03) necrosis and energy delivered, with tumour tumour cells in the necrotic tumour area. Bar: 50 jLm necrosis of 35.7 ± 9.8% at 800 J cmu' and 54.0 ± 12.3% at 1600 J cm-', accompanied by liver necrosis of 1.4 ± 0.9% and 5.0 ± 3.5% respectively (Figure 7b ). Tumour necrosis in this group was limited to the central area around the diffuser and had a similar appearance as the earlier described photodynamic damage. Liver necrosis occurred only at the dorsal tumour border, where the diffuser probably had penetrated hepatic tissue.
Serum ASAT/ALAT Serum ASAT and ALAT levels on the first day after treatment were increased in the experimental group and the control group treated with light only (Figure  8a,b) . The values were related to the amount of light energy applied (P<0.001). After a plateau at 1OOJcmur, however, a strong increase was found at energies over 400 J cm -. No difference was found between ALAT levels of control Figure 6 Histological section on day 2 after PDT. Liver tissue around the portal areas has remained intact. Bar: 150 gtm (haematoxylin, azophloxin and saffron stain). animals treated with Photofrin only compared with diffuser insertion only (P = 0.9). ASAT levels, however, showed a significant difference, with values of 42.4 ± 3.1 IU 1' after Photofrin only compared with 62.4 ± 7.7 IU 1-1 after diffuser insertion (P = 0.01).
On the second day after treatment enzyme levels were still slightly increased with maximum values in the experimental group of 71.7 ± 3.9 IU 1' for ALAT and 119.7 ± 7.5 IU 1' for ASAT at 1600 J cm- '. u LL-jLLj *_ iL _v vjL * *L x/ I %j LL vum o%,%, "%. %&r. "-tion were not related to energy applied (P = 0.29) (Table II) .
_Long-term effect on tumour remission All tumours in control animals showed massive outgrowth with infiltration to adjacent tissue. In the experimental group several animals showed complete tumour remission. Best results were obtained at 800Jcm-' with complete remission in 4 out of 6 animals (Table III) . Owing to the unfavourable results at 1600 J cm'1 -merely 1 out of 6 tumours in complete remission -no significant relation was found between number of tumours in remission and light energy delivered (P = 0.08). The size of the tumour area on day 36 after PDT (Table III) solve the problem of efficient photosensitiser accumulation in the liver. Kita et al. (1987) found that indocyanine green after i.v injection, protects photosensitised hepatocytes against illumination with green light. Nishiwaka et al. (1989) used intra-arterial administration of the photosensitiser. Pheophorbide to cause selective accumulation in liver tumours. Interstitial therapy, however, can be applied in combination with Photofrin, the only clinically used photosensitiser, and additionally provides the possibility of treating deep-seated solid tumours. There are no data available on Photofrin distribution of intrahepatic tumour and surrounding liver at different time intervals after administration. We therefore based the interval between Photofrin administration and illumination on previous studies in experimental animals carrying extrahepatic tumours. These studies showed an optimal porphyrin concentration ratio between tumour and liver after a period of 2 days (Gomer & Dougherty, 1979; Cozzani et al., 1984; Jori et al., 1986 ).
An increase in light dose delivered, resulted in a higher percentage of tumour necrosis in the experimental group, with maximum values of 99.0 ± 0.6% at 1600 J cm-' (Figure  7a) . Remarkably, tumour necrosis also appeared in control animals treated with laser light only (Figure 7b) . Bown et al. (1986) have studied the effects of different power outputs on PDT in normal rat liver. They found that 400 mW red light from an interstitial bare tipped fibre significantly heated the tissue, resulting in charring at the fibre tip within 1 min. The light transmission in the tissue dropped accordingly to under 10%. At 100 mW power output, however, light transmission remained constant and no thermal tissue changes were found. In the present study we used the same power output of 100 mW, from a 0.5 cm cylindrical diffuser (i.e. 200 mW cm-'). By using a diffuser, the light is emitted from a larger surface area resulting in a more uniform light delivery. Thus the heat generated in this manner is much less localised and intense than with a bare fibre tip. Indeed, charring could not be observed on histological specimen and temperature at the tumour boundary was always less than 40C. However, as tumour necrosis in the control group treated with light only was limited to the area around the diffuser, higher temperatures might have occurred there resulting in hyperthermic effects at longer exposures. Another explanation, however, might be the activation of pre-existent endogenous porphyrins (Van Hillegersberg et al., 1992b) .
Although PDT has been shown to be synergistic with hyperthermia (Waldow & Dougherty, 1984; Waldow et al., 1987; Matsumoto et al., 1990) , thermal influences are normally avoided in fundamental studies to investigate exclusively the PDT effect. A power output of 200 mW cm' was therefore applied in this study. However, as PDT damage depends largely on the total energy delivered (Joules = Watts x seconds), the exposure time has to be correspondingly longer at lower dose rates. We used a maximal exposure time of 2 h and 13 min (1600 J cm-') in this study. In clinical PDT, however, higher power outputs may be applied (as long as charring is avoided) to keep exposure time within boundaries. For example 400 mW cm-, delivered interstitially during 8-12 min (200-300 J cm-') is a standard treatment for patients with endobronchial tumours (Balchum & Doiron, 1985) .
Tumour growth retardation, as measured by the tumour area on the 36th day after PDT, was related to the amount of light energy delivered as would be expected from the amount of tumour necrosis on the second day after treatment. Up to 800 J cm-', a similar relation was found for the number of tumours in complete remission. The unfavourable results at 1600 J cm-1, however, led to an overall nonsignificant relation between tumour remission and energy applied, suggesting an optimum relation between light dose and tumour response (Table III) . From the current knowledge of the photodynamic reaction, however, these results can hardly be explained. Singlet oxygen, the most important cytotoxic agent in PDT, is generated via the so-called Type II mechanism of photosensitised oxidation (Weishaupt et al., 1976; Keene et al., 1986; Foote, 1991) . Upon absorption of a photon, the porphyrin molecule is brought to an excited singlet state that undergoes intersystem crossover to the excited triplet state. Transfer of energy from the triplet photosensitiser to available oxygen creates the reactive singlet oxygen. The electrophilic nature of singlet oxygen makes it very efficient at producing oxidised forms of biomolecules (Gomer, 1989) . Thus, the photocytotoxic reaction occurs exclusively during illumination, which makes it unlikely that doubling the light dose (i.e. from 800 J cm-' to 1600 J cm-') would reduce the photodynamic effect.
The appearance of nests of apparently therapy resistant tumour cells in the necrotic area after PDT has previously been described by Pimstone et al. (1982) and Holt et al. (1985) in rat hepatoma. There could be several mechanisms underlying this phenomenon, assuming the heterogeneity of tumour tissue:
(1) The incorporation of Photofrin in these cells is disturbed as a result of poor vascular supply or altered transmembrane passage which may cause low levels of photosensitiser.
(2) The cells are in a dormant state with very low 02 metabolism and no singlet oxygen production. (3) Vessels with a diameter larger than 1.3 mm produce a cytoprotective shadowing effect, thus preventing appropriate illumination of the cells (Pimstone et al., 1982 (Figure 6 ). This phenomenon is probably due to a different hepatocyte environment (perfusion, and hence supply of nutrients) and enzyme content in the periportal compared with pericentral domains (Lamers et al., 1989) . Thus, substances such as unsaturated fatty acids, that act as oxygen scavengers, and higher concentrations of enzymes such as superoxide dis-mutases would prevent oxidative damage in the periportal areas (Jungermann & Katz, 1989; Byczkowski & Gessner, 1988; Gutteridge & Halliwell, 1990 (Ackerman et al., 1988) . The mechanism responsible for porphyrin accumulation in tumours is still unclear. In a recent study, however, we showed that a decreased conversion to haem, owing to decreased ferrochelatase activity may be an important factor (Van Hillegersberg et al., 1992b) . Dailey & Smith (1984) have shown that several representative porphyrins in Photofrin are substrates for ferrochelatase. Therefore, modulation of this enzyme could be another approach (Smith, 1987) .
As the diffuser was inserted into the centre of the tumour, higher light doses were applied to the tumour than to the surrounding liver tissue. However, on the second day after treatment at all energies a rim of liver necrosis was visible around the tumour, whereas at lower energies tumour tissue had remained largely intact. This could be the result of the unfavourable porphyrin concentration ratio between liver and tumour, which was found to be 3:1 after i.v. Photofrin in this model (Van Hillegersberg et al., 1992b) .
In this study liver necrosis increased with energy delivered, but a plateau occurred beyond 400 J cm-', indicating that higher laser energies could be applied without much more liver damage. An important factor in this matter is the difference in optical properties between the dark red coloured liver and the whitish tumour (Van Hillegersberg et al., 1992c) . The hepatic tissue effectively absorbs 625 nm light, which limits the light penetration in liver, and by that limits liver damage. This difference in absorption coefficient might be beneficial in the clinical application, where the peripheral interstitial diffuser would produce a comparable amount of liver damage.
Serum ASAT and ALAT levels on the first and second day after treatment were used as biochemical parameters for liver damage. Indeed a significant relation between enzyme level and delivered light energy was found, confirming our measurements on the area of hepatic necrosis in the experimental group. However, the rise in ASAT level after diffuser insertion only, did not correspond to the normal histological appearance of surrounding liver tissue. Recently we measured ASAT and ALAT concentrations in rat liver and tumour CC531. The ALAT concentration ratio between tumour and liver was found to be 1:40, whereas ASAT ratio was 1:2, indicating that the serum ALAT level is the most appropriate parameter for liver damage in this model (unpublished data). Thus the increase in serum ASAT after diffuser insertion is probably due to tumour, rather than liver damage. A similar explanation could be applied to the rise in ASAT level after treatment with light only, especially at energies (400J cm '. In this group liver necrosis appeared at 800 and 1600 J cm-1, resulting in a higher ALAT level (Figures 7 and   8 ).
In this study we used a single PDT treatment with a fixed diffuser position to determine the photodynamic effects as standardised as possible. We therefore chose a tumour model in the rat, where the mean diameter of the tumour at time of treatment was approximately 6 mm so that the effects on the tumour and on the adjacent liver tissue could be determined. Larger tumours, however, could be treated by multiple diffuser implantation (Marijnissen et al., 1992) . In this respect, fluence measurements at the tumour boundary would give important information to compare with the light dose delivered in this study (i.e. 170 ± 30 Jcm2 with 400 J cm-I from the diffuser). As the diffuser can be passed down a needle under ultrasound guiding, percutaneous treatment of several tumours at different liver lobes would be possible (Gatenby et al., 1987) . This local treatment of tumour can substantially reduce the surgical trauma and may as such diminish complications like bleeding and liver failure.
